echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance will open bids on February 25

    The Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance will open bids on February 25

    • Last Update: 2022-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On February 23, 2022, the Shanghai Pharmaceutical Centralized Bidding and Purchasing Administration issued the precautions for submitting application materials for centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance
    .
     
    The notice shows that the information disclosure conference for centralized drug procurementin the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions will be held on February 25, 2022 (Friday)
    .
     
    Place of submission of application materials: Lobby, 1st Floor, No.
    622 Jumen Road, Huangpu District, Shanghai; Submission time: From 9:00 am on February 25, 2022 (Friday) to 11:00 am on February 25, 2022 (Friday) deadline
    .
     
    The information disclosure time will start at 13:00 on February 25, 2022 (Friday)
    .
     
    In addition, according to the requirements of epidemic prevention and control, this declaration information disclosure conference will be conducted by live broadcast, and there will be no seats for declaration companies to watch the conference
    .
    The applicant enterprise can log in and watch through the website, user name and password issued by the Alliance Procurement
    Working Group on the day when the application materials are submitted .
    Persons with a history of living in medium and high-risk areas within 14 days will not be allowed to submit application materials on site.
    The person submitting the materials must present a paper report with a negative nucleic acid test certificate within 48 hours.
    The paper report will be retained by the Alliance Procurement Working Group
    .
     
    On January 24, 2022, Shanghai Sunshine Pharmaceutical Purchasing Network released the documents for the centralized procurement of drugs in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance areas.
    Procurement
    .
     
      The content of the document shows that a total of 47 varieties participated in the centralized procurement of the alliance, including oral normal-release dosage forms, injections, tablets, and granule dosage forms
    .
    The products participating in the centralized procurement this time are divided into 3 cases, all of which have been included in the national centralized procurement before, including levofloxacin eye drops, atorvastatin oral normal-release dosage form, rosuvastatin oral normal-release dosage form, irbe Sartan Oral Regular Release Form, Escitalopram Oral Regular Release Form, Omeprazole Oral Regular Release Form, Desloratadine Oral Regular Release Form, Finasteride Oral Regular Release Form, Fluoxetine Oral Regular Release Form Sildenafil citrate tablets, oral normal-release formulations of mecobalamin, etc.
    are all large varieties
    .

      On February 23, 2022, the Shanghai Pharmaceutical Centralized Bidding and Purchasing Administration issued the precautions for submitting application materials for centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance
    .
     
    The notice shows that the information disclosure conference for centralized drug procurement   in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions will be held on February 25, 2022 (Friday)
    .
     
      Place of submission of application materials: Lobby, 1st Floor, No.
    622 Jumen Road, Huangpu District, Shanghai; Submission time: From 9:00 am on February 25, 2022 (Friday) to 11:00 am on February 25, 2022 (Friday) deadline
    .
     
      The information disclosure time will start at 13:00 on February 25, 2022 (Friday)
    .
     
      In addition, according to the requirements of epidemic prevention and control, this declaration information disclosure conference will be conducted by live broadcast, and there will be no seats for declaration companies to watch the conference
    .
    The applicant enterprise can log in and watch through the website, user name and password issued by the Alliance Procurement
    Working Group on the day when the application materials are submitted .
    Persons with a history of living in medium and high-risk areas within 14 days will not be allowed to submit application materials on site.
    The person submitting the materials must present a paper report with a negative nucleic acid test certificate within 48 hours.
    The paper report will be retained by the Alliance Procurement Working Group
    .
     
      On January 24, 2022, Shanghai Sunshine Pharmaceutical Purchasing Network released the documents for the centralized procurement of drugs in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance areas.
    Procurement
    .
     
      The content of the document shows that a total of 47 varieties participated in the centralized procurement of the alliance, including oral normal-release dosage forms, injections, tablets, and granule dosage forms
    .
    The products participating in the centralized procurement this time are divided into 3 cases, all of which have been included in the national centralized procurement before, including levofloxacin eye drops, atorvastatin oral normal-release dosage form, rosuvastatin oral normal-release dosage form, irbe Sartan Oral Regular Release Form, Escitalopram Oral Regular Release Form, Omeprazole Oral Regular Release Form, Desloratadine Oral Regular Release Form, Finasteride Oral Regular Release Form, Fluoxetine Oral Regular Release Form Sildenafil citrate tablets, oral normal-release formulations of mecobalamin, etc.
    are all large varieties
    .

      On February 23, 2022, the Shanghai Pharmaceutical Centralized Bidding and Purchasing Administration issued the precautions for submitting application materials for centralized drug procurement in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) Alliance
    .
     
    The notice shows that the information disclosure conference for centralized drug procurement   in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance regions will be held on February 25, 2022 (Friday)
    .
    medicines medicines medicines
     
      Place of submission of application materials: Lobby, 1st Floor, No.
    622 Jumen Road, Huangpu District, Shanghai; Submission time: From 9:00 am on February 25, 2022 (Friday) to 11:00 am on February 25, 2022 (Friday) deadline
    .
     
      The information disclosure time will start at 13:00 on February 25, 2022 (Friday)
    .
     
      In addition, according to the requirements of epidemic prevention and control, this declaration information disclosure conference will be conducted by live broadcast, and there will be no seats for declaration companies to watch the conference
    .
    The applicant enterprise can log in and watch through the website, user name and password issued by the Alliance Procurement
    Working Group on the day when the application materials are submitted .
    Persons with a history of living in medium and high-risk areas within 14 days will not be allowed to submit application materials on site.
    The person submitting the materials must present a paper report with a negative nucleic acid test certificate within 48 hours.
    The paper report will be retained by the Alliance Procurement Working Group
    .
    Enterprise Enterprise Enterprise Procurement Procurement Procurement
     
      On January 24, 2022, Shanghai Sunshine Pharmaceutical Purchasing Network released the documents for the centralized procurement of drugs in the Yangtze River Delta (Shanghai, Zhejiang and Anhui) alliance areas.
    Procurement
    .
    medicine medicine medicine
     
      The content of the document shows that a total of 47 varieties participated in the centralized procurement of the alliance, including oral normal-release dosage forms, injections, tablets, and granule dosage forms
    .
    The products participating in the centralized procurement this time are divided into 3 cases, all of which have been included in the national centralized procurement before, including levofloxacin eye drops, atorvastatin oral normal-release dosage form, rosuvastatin oral normal-release dosage form, irbe Sartan Oral Regular Release Form, Escitalopram Oral Regular Release Form, Omeprazole Oral Regular Release Form, Desloratadine Oral Regular Release Form, Finasteride Oral Regular Release Form, Fluoxetine Oral Regular Release Form Sildenafil citrate tablets, oral normal-release formulations of mecobalamin, etc.
    are all large varieties
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.